Dexco revenue and financials
R$6.81Change from previous close: +10.37%Absolute change: +R$0.64
In the fiscal year ended December 2025, Dexco reported revenue of R$8.25B (+0.17% year over year). Net income was R$1.18M, a net margin of 0.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +0.17%
- 2025 vs 2024
- Net income growth
- −99.31%
- 2025 vs 2024
- Net margin
- 0.0%
- 2024: 2.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 2,232 | 2,019 | 2,097 | — | 2,122 | 1,903 |
| Cost of revenue | 1,682 | 1,465 | 1,510 | — | 1,635 | 1,457 |
| Gross profit | 550 | 554 | 587 | — | 487 | 446 |
| Selling, general and administrative | 394 | 273 | 314 | — | 393 | 274 |
| Operating income | 168 | 188 | 216 | — | 103 | 73.5 |
| EBIT | 303 | 341 | 200 | — | 272 | 226 |
| EBITDA | 696 | 670 | 498 | — | 662 | 513 |
| Interest expense | 306 | 286 | 272 | — | 275 | 221 |
| Pre-tax income | -3.5 | 55.2 | -72.0 | — | -3.2 | 5.3 |
| Income tax | -18.4 | -16.7 | -23.7 | — | -41.8 | -53.3 |
| Net income | -12.9 | 53.3 | -87.5 | — | 31.7 | 45.9 |
| Net income to common shareholders | -12.9 | 53.3 | -87.5 | — | 31.7 | 45.9 |
| Basic EPS | -0.01 | 0.06 | — | 0.01 | 0.04 | 0.05 |
| Diluted EPS | -0.01 | 0.06 | — | 0.01 | 0.03 | 0.05 |
| Average shares (basic) | 904 | 907 | — | 917 | 904 | 1,156 |
| Average shares (diluted) | 904 | 910 | — | 917 | 909 | 1,156 |